Restructuring hitting multinational drug firms

Published: 2012-05-07 07:00:00

Updated: 2012-05-07 07:00:00

Foreign invested pharmaceutical firms have been taking steps to reduce their workforces as they brace for lower earnings due to the government’s pressure to reduce drug prices.

Three multinational firms, such as Sanofi Aventis Korea, AstraZeneca Korea and GlaxoSmithKline, saw their earnings de...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK